[How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].
The study group on hemostasis and thrombosis calls the attention of the physicians to the fact that the Brussels community office has recommended the adoption of a new mode of expression of the results of the Quick time.
D015110:4-Hydroxycoumarins; D000925:Anticoagulants / Q000008:administration & dosage*; D006801:Humans; D007192:Indenes; D011517:Prothrombin Time / Q000592:standards*; D014812:Vitamin K / Q000008:administration & dosage / Q000037:antagonists & inhibitors*
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D007192:Indenes; C011664:antivitamins K; D014812:Vitamin K
Pour mieux surveiller un traitement anticoagulant par les antivitamines K. Recommandation du Groupe d'Etude sur l'Hémostase et la Thrombose.